tiprankstipranks
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Income Statement

Compare
4,462 Followers

BioNTech SE Income Statement

Last quarter (Q3 2024), BioNTech SE's total revenue was €1.24B, an increase of 39.04% from the same quarter last year. In Q3, BioNTech SE's net income was €198.10M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 3.82B€ 17.31B€ 18.98B€ 482.32M€ 108.59M
Gross Profit
€ 3.22B€ 12.78B€ 15.12B€ -222.04M€ -135.24M
Operating Expenses
€ 2.53B€ 135.90M€ 200.10M€ -139.62M€ 46.28M
Depreciation and Amortization
€ 183.40M€ 121.08M€ 78.20M€ 36.10M€ 33.80M
EBITDA
€ 1.09B€ 12.43B€ 15.00B€ -105.10M€ -152.30M
Operating Income
€ 690.40M€ 12.64B€ 15.28B€ -82.42M€ -181.52M
Other Income/Expenses
€ 495.70M€ 311.40M€ -237.40M€ -63.40M€ 2.10M
Pretax Income
€ 1.19B€ 12.95B€ 15.05B€ -145.80M€ -179.44M
Net Income
€ 930.30M€ 9.43B€ 10.29B€ 15.20M€ -179.17M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 3.83€ 38.08€ 43.87€ 0.06€ -0.85
Diluted EPS
€ 3.83€ 37.09€ 41.21€ 0.06€ -0.85
Weighted Average Shares Outstanding
242.90M 243.30M 244.00M 235.44M 211.50M
Weighted Average Shares Outstanding (Diluted)
242.70M 249.80M 259.70M 248.53M 211.50M
Currency in EUR

BioNTech SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis